Responses
Immune cell therapies and immune cell engineering
Original research
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Compose a Response to This Article
Other responses
No responses have been published for this article.
